by Dr. Melanie Georgiou
Project Ref. BB/K011154/1
The current project is aimed at generating stable allogeneic cell lines from olfactory ensheathing cells for the treatment of spinal cord injury. The project aims to develop a new cell line with pioneering British regenerative medicine company ReNeuron. This project aims to address a key bioprocess challenge, which is to create new platform technologies that have generic potential for large-scale expansion of therapeutic cell products to fulfil the needs of the industry and facilitate safe administration of novel treatments.
Project Ref. BB/K011154/1
The current project is aimed at generating stable allogeneic cell lines from olfactory ensheathing cells for the treatment of spinal cord injury. The project aims to develop a new cell line with pioneering British regenerative medicine company ReNeuron. This project aims to address a key bioprocess challenge, which is to create new platform technologies that have generic potential for large-scale expansion of therapeutic cell products to fulfil the needs of the industry and facilitate safe administration of novel treatments.